ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,870Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 294

$1.39M Total Retail Price of All Prescriptions

Rank: 1 out of 294

321 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 321 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

8% of this provider’s 321 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

1% of this provider’s 16,465 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

44% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $84 among peers.

Prescriptions per Patient

53 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
NEXIUM 577 577 1 36
METOPROLOL SUCCINATE 548 543 2 1
ATORVASTATIN CALCIUM 422 420 3 4
LIDODERM 413 413 4 44
CLONIDINE HCL 411 378 5 34
CARVEDILOL 380 372 6 8
AMLODIPINE BESYLATE 357 357 7 3
NITROGLYCERIN PATCH 349 349 8 35
SPIRONOLACTONE 348 343 9 20
MECLIZINE HCL 330 330 10 51
FUROSEMIDE 277 274 11 5
SPIRONOLACTONE-HCTZ 271 260 12 53
CELEBREX 259 259 13 59
LEVOTHYROXINE SODIUM 258 244 14 25
AMLODIPINE BESYLATE-BENAZEPRIL 253 246 15 32
DIOVAN 238 238 16 24
ZOLPIDEM TARTRATE 235 235 17 48
ISOSORBIDE DINITRATE 232 231 18 55
ISOSORBIDE MONONITRATE ER 227 227 19 17
DIOVAN HCT 220 209 20 40
PLAVIX 217 202 21 14
SIMVASTATIN 216 216 22 7
CLOPIDOGREL 208 200 23 10
VOLTAREN 206 206 24 67
CRESTOR 205 205 25 13
METOPROLOL TARTRATE 204 189 26 6
BENICAR HCT 203 203 27 68
TAMSULOSIN HCL 201 201 28 45
POTASSIUM CHLORIDE 178 178 29 21
DIGOXIN 177 177 30 16
LISINOPRIL 166 153 31 2
COREG CR 157 157 32 56
CLONIDINE 157 157 32 66
ALENDRONATE SODIUM 156 142 34 57
AZOR 145 145 35 82
NIFEDIPINE ER 143 142 36 39
NITROSTAT 141 141 37 23
METFORMIN HCL 140 137 38 30
LANSOPRAZOLE 139 139 39 85
TOPROL XL 120 120 40 88
LIPITOR 117 110 41 33
POLYETHYLENE GLYCOL 3350 117 117 41 90
LOVAZA 116 115 43 64
VYTORIN 114 114 44 71
PROPAFENONE HCL 109 109 45 96
ATENOLOL 109 98 45 12
ADVAIR DISKUS 105 104 47 98
GLIMEPIRIDE 103 92 48 60
EXFORGE 98 98 49 79
ACTOS 97 97 50 100
HYDROCHLOROTHIAZIDE 96 79 51 18
DONEPEZIL HCL 92 92 52 46
WARFARIN SODIUM 91 91 53 9
NASONEX 89 87 54 102
AMIODARONE HCL 87 87 55 22
CYCLOBENZAPRINE HCL 84 73 R 56 103
LUNESTA 84 84 56 103
RANITIDINE HCL 83 83 58 77
COLCRYS 80 80 59 106
ACETAMINOPHEN-CODEINE 76 75 S3 60 79
ACTONEL 76 76 60 110
PROCTOZONE-HC 75 75 62 111
JANUVIA 74 74 63 112
PROPRANOLOL HCL 72 72 64 114
GABAPENTIN 68 57 65 81
PANTOPRAZOLE SODIUM 68 68 65 50
DILTIAZEM 24HR CD 68 68 65 42
ALLOPURINOL 67 67 68 58
SINGULAIR 67 65 68 121
ZETIA 67 58 68 26
CREON 66 66 71 123
FEXOFENADINE HCL 61 61 72 130
EPLERENONE 59 59 73 134
RANEXA 58 58 74 38
PROAIR HFA 56 56 75 137
NITRO-DUR 54 54 10 76 139
OMEPRAZOLE 54 42 76 37
LOSARTAN-HYDROCHLOROTHIAZIDE 52 51 78 28
DEXILANT 51 44 79 144
BYSTOLIC 50 50 80 27
CILOSTAZOL 50 50 80 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 28, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.